First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
20.05
+1.95 (10.77%)
At close: Apr 28, 2026, 4:00 PM EDT
19.56
-0.49 (-2.44%)
After-hours: Apr 28, 2026, 7:58 PM EDT
TRAX Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -166.09 | -163.71 | -106.15 |
| Depreciation & Amortization | 2.42 | 2.4 | 2.38 |
| Loss (Gain) From Sale of Investments | -4.73 | -10.31 | -10.52 |
| Stock-Based Compensation | 32.3 | 26.83 | 18.39 |
| Change in Accounts Payable | -5.31 | 17.81 | 8.39 |
| Change in Other Net Operating Assets | -1.52 | 1.18 | -5.49 |
| Operating Cash Flow | -142.93 | -125.81 | -93 |
| Capital Expenditures | -0.09 | -0.36 | -0.81 |
| Investment in Securities | 228.12 | 95.76 | 145.56 |
| Investing Cash Flow | 228.03 | 95.4 | 144.75 |
| Issuance of Common Stock | 30.01 | 117.52 | - |
| Other Financing Activities | - | - | -87.09 |
| Financing Cash Flow | 30.01 | 117.52 | -87.09 |
| Net Cash Flow | 115.12 | 87.12 | -35.34 |
| Free Cash Flow | -143.01 | -126.16 | -93.81 |
| Levered Free Cash Flow | -82.76 | -63.42 | - |
| Unlevered Free Cash Flow | -82.76 | -63.42 | - |
| Change in Working Capital | -6.83 | 18.99 | 2.9 |
Source: S&P Capital IQ. Standard template.
Financial Sources.